Loading clinical trials...
Loading clinical trials...
An Open-label, Randomised Study Comparing the Uptake of rIL-2 in HIV-1 Infected Individuals Receiving Different Combinations of Antiemetics and Analgesic Agents During rIL-2 Dosing in ESPRIT: Toxicity Substudy of ESPRIT: TOXIL-2 Substudy
Conditions
Interventions
ondansetron, ibuprofen, paracetamol
Ondansetron, ibuprofen, paracetamol
+2 more
Locations
16
Argentina
Hospital General de Agudos JM Ramos Mejia
Buenos Aires, Buenos Aires, Argentina
FUNCEI
Buenos Aires, Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, Argentina
Hospital Prof. Alejandro Posadas
Buenos Aires, Argentina
Hospital Interzonal de Agudos San Juan de Dios
La Plata, Argentina
Hospital Interzonal General de Agudos Oscar Alende
Mar del Plata, Argentina
Start Date
November 1, 2005
Primary Completion Date
November 1, 2008
Completion Date
December 1, 2008
Last Updated
April 12, 2012
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Kirby Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions